Literature DB >> 21059911

Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer.

Stefano Cairo1, Yipeng Wang, Aurélien de Reyniès, Karine Duroure, Jennifer Dahan, Marie-José Redon, Monique Fabre, Michael McClelland, Xin W Wang, Carlo M Croce, Marie-Annick Buendia.   

Abstract

Myc activation has been implicated in the pathogenesis of hepatoblastoma (HB), a rare embryonal neoplasm derived from liver progenitor cells. Here, microRNA (miR) expression profiling of 65 HBs evidenced differential patterns related to developmental stage and Myc activity. Undifferentiated aggressive HBs overexpressed the miR-371-3 cluster with concomitant down-regulation of the miR-100/let-7a-2/miR-125b-1 cluster, evoking an ES cell expression profile. ChIP and Myc inhibition assays in hepatoma cells demonstrated that both miR clusters are regulated by Myc in an opposite manner. We show that the two miR clusters exert antagonistic effects on cell proliferation and tumorigenicity. Moreover, their combined deregulation cooperated in modulating the hepatic tumor phenotype, implicating stem cell-like regulation of Myc-dependent miRs in poorly differentiated HBs. Importantly, a four-miR signature representative of these clusters efficiently stratified HB patients, and when applied to 241 hepatocellular carcinomas (HCCs), it identified invasive tumors with a poor prognosis. Our data argue that Myc-driven reprogramming of miR expression patterns contributes to the aggressive phenotype of liver tumors originating from hepatic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059911      PMCID: PMC2996672          DOI: 10.1073/pnas.1009009107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  SIOPEL trials using preoperative chemotherapy in hepatoblastoma.

Authors:  G Perilongo; E Shafford; J Plaschkes
Journal:  Lancet Oncol       Date:  2000-10       Impact factor: 41.316

Review 3.  The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds.

Authors:  Barbara A Hirschman; Brad H Pollock; Gail E Tomlinson
Journal:  J Pediatr       Date:  2005-08       Impact factor: 4.406

4.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 5.  The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis.

Authors:  Arthur Zimmermann
Journal:  Eur J Cancer       Date:  2005-07       Impact factor: 9.162

6.  Characterization of microRNAs involved in embryonic stem cell states.

Authors:  Bradford Stadler; Irena Ivanovska; Kshama Mehta; Sunny Song; Angelique Nelson; Yunbing Tan; Julie Mathieu; Christopher Darby; C Anthony Blau; Carol Ware; Garrick Peters; Daniel G Miller; Lanlan Shen; Michele A Cleary; Hannele Ruohola-Baker
Journal:  Stem Cells Dev       Date:  2010-07       Impact factor: 3.272

7.  MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.

Authors:  Catherine M Shachaf; Andrew M Kopelman; Constadina Arvanitis; Asa Karlsson; Shelly Beer; Stefanie Mandl; Michael H Bachmann; Alexander D Borowsky; Boris Ruebner; Robert D Cardiff; Qiwei Yang; J Michael Bishop; Christopher H Contag; Dean W Felsher
Journal:  Nature       Date:  2004-10-10       Impact factor: 49.962

8.  Human embryonic stem cells express a unique set of microRNAs.

Authors:  Mi-Ra Suh; Yoontae Lee; Jung Yeon Kim; Soo-Kyoung Kim; Sung-Hwan Moon; Ji Yeon Lee; Kwang-Yul Cha; Hyung Min Chung; Hyun Soo Yoon; Shin Yong Moon; V Narry Kim; Kye-Seong Kim
Journal:  Dev Biol       Date:  2004-06-15       Impact factor: 3.582

9.  Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.

Authors:  A Koch; D Denkhaus; S Albrecht; I Leuschner; D von Schweinitz; T Pietsch
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

10.  PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts.

Authors:  Stefano Cairo; Francesca De Falco; Mariateresa Pizzo; Paolo Salomoni; Pier Paolo Pandolfi; Germana Meroni
Journal:  Oncogene       Date:  2005-03-24       Impact factor: 9.867

View more
  81 in total

Review 1.  MicroRNAs in liver disease.

Authors:  Xin Wei Wang; Niels H H Heegaard; Henrik Orum
Journal:  Gastroenterology       Date:  2012-04-11       Impact factor: 22.682

Review 2.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

3.  Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin.

Authors:  Sarah A Comerford; Elizabeth A Hinnant; Yidong Chen; Hima Bansal; Shawn Klapproth; Dinesh Rakheja; Milton J Finegold; Dolores Lopez-Terrada; Kathryn A O'Donnell; Gail E Tomlinson; Robert E Hammer
Journal:  JCI Insight       Date:  2016-10-06

4.  MicroRNA-based screens for synthetic lethal interactions with c-Myc.

Authors:  Youjun Li; Yahui Zhu; Edward V Prochownik
Journal:  RNA Dis       Date:  2016-05-30

5.  Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice.

Authors:  Shannon Glaser; Fanyin Meng; Yuyan Han; Paolo Onori; Billy K Chow; Heather Francis; Julie Venter; Kelly McDaniel; Marco Marzioni; Pietro Invernizzi; Yoshiyuki Ueno; Jia-ming Lai; Li Huang; Holly Standeford; Domenico Alvaro; Eugenio Gaudio; Antonio Franchitto; Gianfranco Alpini
Journal:  Gastroenterology       Date:  2014-02-25       Impact factor: 22.682

6.  Role of Myc in hepatocellular proliferation and hepatocarcinogenesis.

Authors:  Aijuan Qu; Changtao Jiang; Yan Cai; Jung-Hwan Kim; Naoki Tanaka; Jerrold M Ward; Yatrik M Shah; Frank J Gonzalez
Journal:  J Hepatol       Date:  2013-10-02       Impact factor: 25.083

7.  miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.

Authors:  G Yang; Y Gong; Q Wang; L Wang; X Zhang
Journal:  Oncogene       Date:  2016-08-15       Impact factor: 9.867

8.  Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.

Authors:  Zheng Chen; Rama Saad; Peilin Jia; DunFa Peng; Shoumin Zhu; M Kay Washington; Zhongming Zhao; Zekuan Xu; Wael El-Rifai
Journal:  Cancer       Date:  2013-03-01       Impact factor: 6.860

Review 9.  Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges.

Authors:  Gurpreet Kaur; Praveen Sharma; Nilambra Dogra; Sandeep Singh
Journal:  Curr Treat Options Oncol       Date:  2018-03-20

10.  MicroRNA expression might predict prognosis of epithelial hepatoblastoma.

Authors:  Mónika Gyugos; Gábor Lendvai; István Kenessey; Krisztina Schlachter; Judit Halász; Péter Nagy; Miklós Garami; Zsuzsa Jakab; Zsuzsa Schaff; András Kiss
Journal:  Virchows Arch       Date:  2014-02-26       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.